Back to Results
First PageMeta Content
Generally Accepted Accounting Principles / Financial economics / Financial ratio / Pharmaceutical industry / Pfizer / IMS Health / Hikma / BioPharm / Income statement / Finance / Business / Pharmaceutical sciences


HIKMA PHARMACEUTICALS (HIK) Equity Research Report H1 2009 Results Update P.O. Box[removed], Amman 11193, Jordan
Add to Reading List

Document Date: 2009-09-27 09:58:48


Open Document

File Size: 542,75 KB

Share Result on Facebook

City

Sofia / /

Company

O PDL BioPharma Inc. / L Ipsen S.A. / Hikma Italia S.p.A / Johnson & Johnson / Bayer / O Myriad Genetics Inc / Aventis / West-Ward Pharmaceuticals Corp. / Novartis / ABC / The Medicines Co / Hikma Pharma Algeria / Lp Schwarz Pharma AG / Pharmaceutical Sector - Hikma Pharmaceuticals / Alkan Pharma / Lp Antibiotice SA / zdravil d.d. / Ge / 4th Algeria Hikma / Hikma Pharma GmbH / L UCB S.A. / Hikma Pharma SAE Egypt / Hikma Farmaceutica S.A. / Hikma Pharmaceuticals Hikma Pharmaceuticals / Top 9 MENA / Branded Pharmaceuticals / Pfizer / Lp Biotest AG / Glaxosmithkline / O Chattem Inc. / Ribosepharm GmbH / Prestige Brands Holdings Inc. / Teikoku Pharma USA / O Biomarin Pharmaceutical Inc. / IMS Health / Lp Zentiva SA / K.S.A. / Sanofi / Pharma Ixir Co. Sudan / Lp Biovitrum AB / HIKMA PHARMACEUTICALS / Hikma Italy / Arab Pharmaceutical Manufacturing Company / Country Ownership (%) Hikma Pharmaceutical Ltd / L Shire Plc / Astrazeneca / London Stock Exchange / Hikma Pharmaceutical PLC / Jazeera Pharmaceutical Industries / L Dechra Pharmaceuticals PLC / Thymoorgan Pharmazie GmbH / Information London Stock Exchange / Zein Alkhas Equity Research / /

Continent

Europe / /

Country

Germany / Saudi Arabia / Italy / Algeria / Tunisia / Libya / Sudan / Egypt / Jordan / United States / Portugal / United Kingdom / Morocco / Iraq / /

Currency

pence / cent / SHP / USD / /

/

Event

M&A / Dividend Issuance / Business Partnership / Company Expansion / Product Release / /

Facility

Terminal Value / Terminal Growth Rate / Terminal Value Free Cash Flow / /

/

IndustryTerm

owned subsidiary / manufacturing facilities / anti-infective products / higher margin products / pharmaceuticals / retail sales / peer / manufacturing operations / manufacturing plants / Bank loans / /

MarketIndex

FTSE 250 / /

Organization

Equity Research Department / Total Assets Research Department / FDA / /

Person

Tanya Khammash / /

/

Position

Analyst / Forward / CVA Head / /

Product

Injectables / Actos / /

ProvinceOrState

New Jersey / /

Region

North Africa / East North Africa / Eastern Europe / /

URL

www.abci.com.jo / /

SocialTag